V. V. Fomin
|
|
M.B. Antsiferov
Glucagon-like Peptide-1: From Physiology To Effective Management Of Type 2 Diabetes Mellitus
|
9-15 |
I.V. Druk, G.I. Nechayeva, O.Yu. Korennova
Sitagliptin: Current Positions And Prospects For Therapy Of Type 2 Diabetes Mellitus
|
16-21 |
M.B. Antsiferov (1), N.A. Petunina (2)
Type 2 Diabetes Mellitus And Concomitant Diseases: Advantages Of Use Of Dipeptidyl Peptidase-4 Inhibitor Saxagliptin (onglyza ®)
|
22-28 |
M.B. Antsiferov
Application Of Vildagliptin In Combination With Insulin In Type 2 Diabetes Mellitus
|
29-33 |
O. M. Smirnova, I.V. Kononenko
Sulfonylureas In The Treatment Of Type 2 Diabetes Mellitus Today. Is There A Prospect?
|
34-42 |
Ye.V. Biryukova (1), M.B. Antsiferov (2)
How To Effectively Manage Two Major Defects In Type 2 Diabetes Mellitus?
|
43-48 |
T.V. Nikonova
Sustained-release Metformin (glucophage Long) In The Management Of Type 2 Diabetes Mellitus
|
49-52 |
Ye.V Biryukova
How To Overcome The Effects Of \"hyperglycemic\" Memory?
|
53-57 |
N. A. Chernikova, M.A. Prudnikova
Timely Administration Of Insulin Therapy In Type 2 Diabetes Mellitus
|
58-62 |
Ye.V. Doskina (1), A.V. Doskin (2)
Pain And Its Features In Osteoporosis
|
63-66 |
V.A. Peterkova
Diabetes In Children And Adolescents: To The 90th Anniversary Of The Introduction Of Insulin In Clinical Practice
|
67-74 |
N.V. Vorohobina, A.V. Kuznetsova
Place Of Dibcor® In The Treatment Of Patients With Type 2 Diabetes Mellitus And Metabolic Syndrome
|
75-80 |
I.B. Zhurtova (1), N.A.Strebkova (2)
The Use Of Cabergoline In Children And Adolescents With Hyperprolactinemia Syndrome
|
81-85 |
A.V. Dreval (1), L.S. Logutova (2), Ya.Z. Zaydieva (2), A.V. Perfil’yev (1), M.A. Chechneva (2), I.A. Ilovayskaya (1)
Features Of The Reproductive System And Menopausal Period In Women With Acromegaly
|
86-89 |
O.A. Kiseleva, Ye.N. Iomdina, L.V.Vasilenkova, M.V. Aref\'eva, L.L. Arutyunyan
Use Of Magnesium-containing Drug For The Treatment Of Patients With Primary Open Angle Glaucoma
|
90-95 |